Mirae Asset Global Investments
AXSM icon

Mirae Asset Global Investments’s Axsome Therapeutics AXSM Stock Holding History

Mirae Asset Global Investments’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$563K Sell
2,301
-367
-14% -$79.6K ﹤0.01% 963
2026
Q1 		$451K Buy
2,668
+218
+9% +$37.7K ﹤0.01% 953
2025
Q4 		$447K Buy
2,450
+521
+27% +$72.7K ﹤0.01% 1019
2025
Q3 		$234K Buy
1,929
+27
+1% +$3.04K ﹤0.01% 1107
2025
Q2 		$199K Buy
1,902
+270
+17% +$28.6K ﹤0.01% 1051
2025
Q1 		$193K Buy
1,632
+17
+1% +$1.94K ﹤0.01% 1053
2024
Q4 		$140K Sell
1,615
-121
-7% -$11.1K ﹤0.01% 1099
2024
Q3 		$156K Buy
1,736
+318
+22% +$27.8K ﹤0.01% 1130
2024
Q2 		$114K Sell
1,418
-13,831
-91% -$1.02M ﹤0.01% 1126
2024
Q1 		$964K Sell
15,249
-2,713
-15% -$228K ﹤0.01% 1561
2023
Q4 		$1.43M Buy
17,962
+72
+0.4% +$4.81K ﹤0.01% 1424
2023
Q3 		$1.25M Buy
17,890
+2,645
+17% +$198K ﹤0.01% 1412
2023
Q2 		$1.1M Buy
15,245
+329
+2% +$24.3K ﹤0.01% 1511
2023
Q1 		$920K Sell
14,916
-26
-0.2% -$1.71K ﹤0.01% 1591
2022
Q4 		$1.15M Buy
14,942
+1,794
+14% +$107K ﹤0.01% 1410
2022
Q3 		$587K Buy
+13,148
New +$657K ﹤0.01% 1779

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Mirae Asset Global Investments's AXSM Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Axsome Therapeutics (AXSM) stake by 14% in Q2 2026, selling an estimated $79.6K and leaving 2,301 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Mirae Asset Global Investments first reported a position in AXSM in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.43M in Q4 2023. 207 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Mirae Asset Global Investments held 2,301 shares of Axsome Therapeutics worth $563K as of Q2 2026.
  • Mirae Asset Global Investments sold 367 Axsome Therapeutics shares in Q2 2026, an estimated $79.6K.
  • Axsome Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #963 holding.
  • Mirae Asset Global Investments first reported a position in Axsome Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Mirae Asset Global Investments's Axsome Therapeutics position peaked at $1.43M in Q4 2023.
  • 207 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.